Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Journal Title: 
Blood Advances
Primary Author: 
Komrokji RS
Author(s): 
Komrokji RS, Aguirre LE, Al Ali NH, Chan O, Xie Z, Kuykendall A, Sweet K, Lancet JE, Padron E, Sallman DA
Original Publication Date: 
Tuesday, July 25, 2023
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/37058483/
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.